Did FDA's Pain Med Warning Scare Shionogi Away From Victory?
This article was originally published in The Pink Sheet Daily
Deal to buy Victory, maker of acetaminophen-combo products, disappears into thin air soon after liver injury scare.
You may also be interested in...
In what could be a major blow to manufacturers, acetaminophen sold in 500 mg tablets will come off the OTC market if FDA follows a joint advisory committee's recommendations, but the industry may be spared the additional pain of losing combination products that include acetaminophen and other ingredients.
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions Database, providing comprehensive transaction coverage from 1991 to the present.
Shionogi offers strong pipeline, Sciele brings 770-strong sales force to Japan-U.S. pairing.